特一药业集团股份有限公司股票交易异常波动公告

Core Viewpoint - The stock of Te Yi Pharmaceutical Group Co., Ltd. has experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from November 25 to November 27, 2025 [1][2]. Summary by Sections Stock Trading Abnormal Fluctuation - Te Yi Pharmaceutical's stock price has deviated significantly, indicating abnormal trading activity as per Shenzhen Stock Exchange regulations [1]. Company Verification and Situation - The company confirms that its operations are normal and there have been no significant changes in its internal or external business environment [1]. - There are no corrections or supplements needed for previously disclosed information [1]. - No major undisclosed information has been reported in public media that could impact the stock price [1]. - The company, its controlling shareholders, and actual controllers have no undisclosed significant matters related to the company [1][2]. Disclosure of Information - The board of directors confirms that there are no undisclosed matters that should be reported according to the Shenzhen Stock Exchange's listing rules [2]. - The board has not been made aware of any significant undisclosed information that could affect the company's stock and its derivatives [2].